| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
cytochrome P450 family 1 subfamily A member 2 | 0.494 | 0.923 | 2.5E-10 |
|
disease | 0.210 | None | 0.667 | 2 | 0 | 2005 | 2008 | ||||||||
|
selectin L | 0.505 | 0.846 | 5.0E-07 |
|
disease | 0.210 | None | 0.667 | 2 | 0 | 2005 | 2006 | ||||||||
|
suppressor of cytokine signaling 3 | 0.434 | 0.808 | 0.75 |
|
disease | 0.220 | None | 0.750 | 2 | 0 | 2001 | 2017 | ||||||||
|
adiponectin, C1Q and collagen domain containing | 0.376 | 0.885 | 4.6E-09 |
|
disease | 0.250 | None | 0.833 | 1 | 0 | 2006 | 2019 | ||||||||
|
ectonucleoside triphosphate diphosphohydrolase 1 | 0.499 | 0.769 | 8.1E-03 |
|
disease | 0.260 | None | 0.857 | 1 | 0 | 2012 | 2019 | ||||||||
|
interleukin 1 receptor antagonist | 0.373 | 0.923 | 3.1E-02 |
|
disease | 0.300 | None | 0.917 | 1 | 0 | 1999 | 2019 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.300 | None | 0.938 | 3 | 0 | 1991 | 2020 | ||||||||
|
serpin family E member 1 | 0.359 | 0.885 | 4.4E-02 |
|
disease | 0.300 | None | 0.944 | 1 | 0 | 1997 | 2019 | ||||||||
|
C-reactive protein | 0.299 | 0.962 | 3.7E-03 |
|
disease | 0.300 | None | 0.957 | 1 | 0 | 1999 | 2020 | ||||||||
|
high mobility group box 1 | 0.368 | 0.923 | 0.82 |
|
disease | 0.600 | None | 0.957 | 1 | 0 | 2004 | 2020 | ||||||||
|
toll like receptor 4 | 0.321 | 0.962 | 4.6E-09 |
|
disease | 0.600 | None | 0.968 | 2 | 0 | 2001 | 2020 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
disease | 0.600 | None | 0.975 | 2 | 0 | 2000 | 2019 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.600 | None | 0.982 | 3 | 0 | 1995 | 2020 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
disease | 0.300 | None | 0.985 | 2 | 0 | 1993 | 2020 | ||||||||
|
toll like receptor 2 | 0.361 | 0.923 | 1.0E-06 |
|
disease | 0.300 | None | 1.000 | 3 | 0 | 2003 | 2020 | ||||||||
|
complement C5 | 0.550 | 0.731 | 8.1E-24 |
|
disease | 0.250 | None | 1.000 | 2 | 0 | 2001 | 2018 | ||||||||
|
complement C5a receptor 1 | 0.513 | 0.808 | 0.40 |
|
disease | 0.290 | None | 1.000 | 2 | 0 | 2001 | 2019 | ||||||||
|
BCL2 associated agonist of cell death | 0.553 | 0.769 | 4.6E-03 |
|
disease | 0.200 | None | 1.000 | 2 | 0 | 2013 | 2014 | ||||||||
|
coagulation factor VII | 0.623 | 0.615 | 1.3E-05 |
|
disease | 0.210 | None | 1.000 | 2 | 0 | 1987 | 2002 | ||||||||
|
heat shock protein family D (Hsp60) member 1 | 0.432 | 0.808 | 0.99 |
|
disease | 0.230 | None | 1.000 | 2 | 0 | 2006 | 2015 | ||||||||
|
suppressor of cytokine signaling 1 | 0.445 | 0.808 | 0.59 |
|
disease | 0.230 | None | 1.000 | 2 | 0 | 2001 | 2019 | ||||||||
|
alpha-2-macroglobulin | 0.529 | 0.769 | 4.5E-11 |
|
disease | 0.210 | None | 1.000 | 2 | 0 | 1998 | 2018 | ||||||||
|
retinoid X receptor alpha | 0.543 | 0.769 | 1.00 |
|
disease | 0.200 | None | 1.000 | 2 | 0 | 2007 | 2009 | ||||||||
|
adrenoceptor beta 2 | 0.442 | 0.923 | 0.53 |
|
disease | 0.210 | None | 1.000 | 2 | 0 | 1999 | 2010 | ||||||||
|
caspase 8 | 0.404 | 0.923 | 3.7E-06 |
|
disease | 0.210 | None | 1.000 | 2 | 0 | 2008 | 2017 |